Avalon GloboCare Corp. Aktie News

Avalon GloboCare Corp (NASDAQ:ALBT) has encouraged its shareholders to vote on a number of key proposals at its upcoming annual meeting to be held on December 29, 2022, at 11am Eastern Time. Shareholders can vote on a new proposed board composition to reflect the company's continued US focus and acquisition of Laboratory Services MSO LLC, Avalon said in a statement.

Avalon GloboCare Corp (NASDAQ:AVCO) is set to buy a 60% stake in Laboratory Services MSO as it expands its focus on lab testing and services in what it called a 'transformative' deal worth $31 million. California-headquartered Laboratory Services has completed over 600,000 tests since inception.

Company to acquire a majority interest in Laboratory Services MSO, LLC,  a leading reference laboratory with 2021 unaudited revenue in excess of $25 million, net income in excess of $10 million and over 600,000 tests completed since inception

What happened in the stock market today and Penny stocks to watch this week. The post Stock Market Today: What Happened & 3 Penny Stocks To Watch Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Avalon GloboCare Corp (NASDAQ:AVCO) has received a notice of allowance from the US Patent and Trademark Office (USPTO) related to its QTY fusion water-soluble receptor protein platform. The company's QTY code is a breakthrough technology that can turn difficult to work with water-insoluble transmembrane receptor proteins into water-soluble proteins, enabling their potential use in many clinical...

Jointly with MIT, the Company also Submitted a New U.S. Patent Application for QTY Glucose Transporters Jointly with MIT, the Company also Submitted a New U.S. Patent Application for QTY Glucose Transporters

Avalon GloboCare Corp (NASDAQ:AVCO) said that an article featuring its QTY protein code technology was published in Chemical Reviews, the official journal of the American Chemical Society.  The publication, titled “Protein Design: From the Aspect of Water Solubility and Stability,” discusses the innovative QTY protein design code, which Avalon co-designed, as a novel platform to generate water-...

Findings support utility of QTY protein code as a novel platform to generate water-soluble proteins for wide spectrum of biomedical applications